CHK
48
15
URI
58
-5
MCO
80
2
CVS
45
-4
PYPL
43
-4
TRV
64
2
TSN
31
-4
BBY
56
-2
HRL
30
-5
TGT
50
-2
NEM
48
2
INTU
63
-2
BIIB
37
7
SHW
71
-2
EBAY
47
-2
AVGO
69
20
ADT
32
9
LMT
47
7
TXN
50
-3
JBHT
50
-6
CHK
48
15
URI
58
-5
MCO
80
2
CVS
45
-4
PYPL
43
-4
TRV
64
2
TSN
31
-4
BBY
56
-2
HRL
30
-5
TGT
50
-2
NEM
48
2
INTU
63
-2
BIIB
37
7
SHW
71
-2
EBAY
47
-2
AVGO
69
20
ADT
32
9
LMT
47
7
TXN
50
-3
JBHT
50
-6
Financhill
Back

WisdomTree New Economy Real Estate ETF Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
36

WTRE
WisdomTree New Economy Real Estate ETF

Last Price:
20.09
Seasonality Move:
-2.56%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
36
WisdomTree New Economy Real Estate ETF (WTRE) is a Sell

Is WisdomTree New Economy Real Estate ETF a Buy, Sell or Hold?

  • The current WisdomTree New Economy Real Estate ETF [WTRE] share price is $19.82. The Score for WTRE is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • WTRE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

WTRE Stock Price Chart

What is WisdomTree New Economy Real Estate ETF's stock price today?

  • The WisdomTree New Economy Real Estate ETF share price today is $19.82
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and WTRE is experiencing slight buying pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

WTRE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.32 Buy
Relative Strength Index (14 RSI): 63.05 Buy
Chaikin Money Flow: -596 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (18.97 - 19.79) Buy
Bollinger Bands (100): (17.34 - 19.06) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

WTRE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 19.89 Sell
20-day SMA: 19.52 Buy
50-day SMA: 18.94 Buy
200-day SMA: 17.89 Buy
8-day EMA: 19.82 Buy
20-day EMA: 19.53 Buy
50-day EMA: 18.99 Buy
200-day EMA: 17.97 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

WisdomTree New Economy Real Estate ETF Earnings Growth & WTRE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

WisdomTree New Economy Real Estate ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):